RENPHO vs InBody: Which Body Composition Scale Actually Fits Your Use Case

↓ Skip to the decision tree

The Honest Top-Line

• Buy a RENPHO if you want a scale for tracking weight and body-composition trends over time at home, your decisions are limited to “am I losing fat or muscle this month,” and you don’t want to spend more than $30-100.
• Buy an InBody H20N if you want individual body composition readings you can actually trust as absolute values, you’re tracking changes that need to be measured in percentage-point precision (cuts and bulks, post-injury rehab, clinical work), or your gym/PT/RD already references InBody numbers and you want at-home consistency with that data.
• Buy neither — get a DEXA scan if you’re making decisions that genuinely depend on knowing your body composition to within ±1%, this is a one-time question, and you can drive to a DEXA clinic ($75-150 per scan).

The rest of this guide explains why those three answers split the way they do.

The Methodology Difference, In Plain Terms

Both RENPHO and InBody use bioelectrical impedance analysis (BIA): a small electrical current is passed through the body, and the resistance (impedance) the current encounters gets converted, via algorithm, into estimates of fat mass, lean mass, body water, and bone mass.

The physics is shared. The execution is not.

What RENPHO does

RENPHO’s foot-only scales (Elis 1, Solar, Aspire, Chrome) use 4 electrodes — two pairs of pads under each foot. Current travels up one leg and down the other, measuring impedance through the lower body only. Upper-body composition is then estimated by algorithm using your demographic inputs (height, weight, age, sex). This is consumer-grade BIA and it’s adequate for trend tracking, not for absolute values.

RENPHO’s flagship Elis 8 and MorphoScan add hand grips on retractable cords — now you have 8 electrodes (four pairs), and current can travel through arms as well as legs. This is methodologically the same approach InBody uses on the H20N, but with consumer-tier sensors, consumer-tier calibration, and a proprietary algorithm RENPHO doesn’t publish.

What InBody does

InBody also uses 8 electrodes on the H20N, but with three significant engineering differences:

1. Multi-frequency BIA. Consumer BIA scales (including RENPHO) use a single electrical frequency (typically 50 kHz) to measure impedance. InBody’s H20N uses two frequencies (20 and 100 kHz), and their commercial-tier devices use three to five. Different frequencies penetrate different tissue types differently — multi-frequency lets the algorithm distinguish intracellular water from extracellular water and produce a more accurate lean-mass reading. This is the biggest single accuracy upgrade in BIA hardware.
2. Segmental analysis, transparently reported. The H20N reports body composition for each body segment (left arm, right arm, trunk, left leg, right leg) separately — and the report distinguishes measured values from algorithm-estimated values. RENPHO’s 8-electrode models do segmental analysis too, but the reporting is less granular and the algorithm’s role in the final number is less transparent.
3. Published validation studies. InBody’s commercial devices have hundreds of peer-reviewed validation studies against DEXA, MRI, and underwater weighing. The H20N is the consumer adaptation of that platform — not the highest-tier InBody, but built on the same algorithmic backbone. RENPHO has no equivalent published-validation body.

Accuracy: What the Data Actually Says

Both scales are validated against DEXA (dual-energy X-ray absorptiometry), the medical gold standard for body composition. Here’s roughly what the published research finds:

The H20N closes most of the gap between consumer BIA and the commercial InBody devices used in clinical research, but it doesn’t fully close it. For a healthy adult at 18-25% body fat, the H20N typically reads within 2 percentage points of DEXA — meaning it can tell you “you’re around 22%” with reasonable confidence. The Elis 1, at the same person, might read 19% one day and 26% the next depending on hydration. The Elis 8 is somewhere in between.

Practical translation: if you’d be comfortable making a training decision based on the number being off by 1-2 percentage points, the H20N is sufficient. If you’d be comfortable being off by 3-5 percentage points, the RENPHO is sufficient. If you need to be within 1%, neither is — book a DEXA.

Price Reality

This is the elephant in the room. The RENPHO Elis 1 is $25-30. The InBody H20N is $300-400. That’s a ~12x price gap, and people are right to ask whether the accuracy delta is worth 12x.

For most home users, the honest answer is no. The Elis 1’s trend signal — am I going up, down, or flat over the last 30 days — is essentially as good as the H20N’s trend signal for that same purpose. If you only care about tracking direction, the cheaper scale gets you there at 1/12th the cost.

The H20N price stops being absurd in three cases:

• You’re tracking absolute body fat, not trends. A cut from 16% to 12% body fat is meaningfully different from a cut from 19% to 15% — and at the consumer-BIA error margin, you can’t reliably tell which one you actually did.
• Your gym/PT/RD uses InBody and you want at-home consistency. InBody H20N readings track much more closely with commercial InBody machines than RENPHO readings do (because they’re using the same multi-frequency methodology). If your fitness coach is making programming decisions off your gym’s InBody, having the same brand at home keeps the numbers comparable.
• You’re tracking post-injury rehab or clinical body composition. Lean mass asymmetries between sides of the body (after ACL surgery, after stroke, after sport-specific injury) need to be measured with segmental precision the consumer scales can’t deliver.

App and Ecosystem

RENPHO wins this one, decisively.

The RENPHO Health app supports unlimited users on the same scale with auto-recognition by weight pattern, native sync to Apple Health, Google Fit, Fitbit, Samsung Health, MyFitnessPal, and Cronometer, decent multi-metric trend graphing, and no aggressive monetization of basic scale-data features.

The InBody app (LookinBody Home for the H20N) is functional but spartan. It tracks your historical readings, generates the InBody-style result sheet you’d recognize from a gym, and syncs to Apple Health and Google Fit. Multi-user support exists but is limited to 4 profiles. The integration list is narrower. The graphing is less mature.

InBody’s app simplicity is partly intentional — it’s a medical-device-style app, not a fitness-app — but the practical effect is that if you want a scale that plays nicely with the rest of your fitness tech stack, RENPHO is easier to live with.

Form Factor

RENPHO scales are flat platforms with embedded foot electrodes. The 8-electrode Elis 8 has retractable hand grips that pull out from the top of the unit. Easy to store flat under furniture.

The InBody H20N is a more substantial device — bigger footprint, taller profile (the hand-grip column is built into a small post), and not really designed to disappear under your bed. It looks like what it is: medical hardware in your bathroom. For some buyers that’s a feature (signals seriousness), for others it’s a problem (where does this thing go).

The Decision Tree

Question 1: Are you using this scale to make decisions that depend on absolute accuracy, or just to track direction?

• Direction only (“am I trending up, down, or flat”) → RENPHO Elis 1. Buy it for $25-30, weigh in consistently, track the 7-day rolling average. Done.
• Absolute accuracy matters (“am I actually 18% body fat or 14%”) → Continue to Question 2.

Question 2: Does your gym, PT, or RD already use InBody?

• Yes → InBody H20N. The methodology alignment is worth the consistency between your in-clinic and at-home readings. Numbers will track more closely than mixing brands.
• No → Continue to Question 3.

Question 3: Will you actually use the scale regularly, or are you considering this as a one-time check?

• One-time check → DEXA scan at a local clinic ($75-150). One scan gives you a clinical-grade reading and saves the $300-400 you’d spend on hardware you might use twice.
• Regular tracking, accuracy matters → InBody H20N. The H20N’s accuracy makes the monthly readings actually trustworthy as absolute values.
• Regular tracking, accuracy is nice-to-have → RENPHO Elis 8 as the middle ground. 8-electrode methodology, ~$80-100, meaningfully more accurate than the Elis 1, much cheaper than the H20N.

Where Each Brand Wins, Plainly

RENPHO wins on

• Price (12x cheaper for the entry-level)
• App ecosystem and integrations
• Multi-user household use (unlimited profiles vs InBody’s 4)
• Form factor (flat, hides under furniture)
• FSA/HSA eligibility on most models
• Long warranty + dense Amazon review history (260k+ on the Elis 1 alone)

InBody wins on

• Absolute accuracy of body composition readings
• Multi-frequency BIA methodology
• Segmental analysis with transparent measured-vs-estimated reporting
• Continuity with gym/clinical InBody readings if your trainer or PT uses one
• Peer-reviewed validation backing the algorithm
• Brand credibility in clinical and sports-science contexts

Who Shouldn’t Buy Either

If you find yourself weighing in daily and getting frustrated when the number doesn’t change, neither scale will fix that. Body composition changes meaningfully over weeks, not days. The right tool for the impatient is a tape measure (waist and hip circumference, which track body recomposition more reliably than weight at the daily timescale) plus a phone camera (monthly progress photos, which catch the body-shape changes both scales miss).

If you have a pacemaker, implanted defibrillator, or other implanted electronic medical device, do not use any BIA scale. The current is small and almost certainly safe, but no manufacturer’s testing has cleared their devices for use with active implants, and the failure mode is bad enough that “almost certainly safe” isn’t good enough.

Last updated: June 28, 2026. Prices and product availability subject to change. This is editorial content — for clinical body composition assessment, work with a physician or registered dietitian.